These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6397516)

  • 1. Effects of prostaglandin synthesis inhibition on blood pressure and humoral factors in exercising, sodium-deplete normal man.
    Staessen J; Fagard R; Lijnen P; Moerman E; De Schaepdryver A; Amery A
    J Hypertens; 1983 Aug; 1(2):123-30. PubMed ID: 6397516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and humoral effects of prostaglandin inhibition in exercising humans.
    Staessen J; Cattaert A; Fagard R; Lijnen P; Moerman E; De Schaepdryver A; Amery A
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Jan; 56(1):39-45. PubMed ID: 6420383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man.
    Speckart P; Zia P; Zipser R; Horton R
    J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin II on arterial pressure, renin and aldosterone during exercise.
    Fagard R; Lijnen P; Amery A
    Eur J Appl Physiol Occup Physiol; 1985; 54(3):254-61. PubMed ID: 3905392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active and acid-activable inactive renin during inhibition by indomethacin of prostaglandin synthesis in sodium-replete man.
    Lijnen P; Staessen J; Fagard R; Groeseneken D; M'Buyamba-Kabangu JR; Grauwels R; Amery A
    Eur J Clin Invest; 1985 Jun; 15(3):141-5. PubMed ID: 3926508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
    Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prostaglandin inhibition by indomethacin on plasma active and inactive renin concentration in men.
    Lijnen P; Staessen J; Fagard R; Amery A
    Can J Physiol Pharmacol; 1991 Sep; 69(9):1355-9. PubMed ID: 1756437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects.
    Ichihara A; Suzuki H; Saruta T
    J Lab Clin Med; 1993 Oct; 122(4):432-40. PubMed ID: 8228558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic and acute changes in sodium balance on the urinary excretion of prostaglandins E2 and F2 alpha in normal man.
    Rathaus M; Podjarny E; Weiss E; Ravid M; Bauminger S; Bernheim J
    Clin Sci (Lond); 1981 Apr; 60(4):405-10. PubMed ID: 7018797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of indomethacin on active and inactive renin in sodium-replete men at rest and during exercise.
    Lijnen P; Groeseneken D; Fagard R; Staessen J; Amery A
    J Lab Clin Med; 1984 May; 103(5):677-83. PubMed ID: 6425442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP; Telfer N; Zia P; Speckart P; Golub M; Rude R
    Am J Med; 1976 May; 60(6):785-97. PubMed ID: 798488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.
    Swartz SL; Williams GH; Hollenberg NK; Levine L; Dluhy RG; Moore TJ
    J Clin Invest; 1980 Jun; 65(6):1257-64. PubMed ID: 6997332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PG synthesis by indomethacin does not influence the exercise induced stimulation of renin-angiotensin-aldosterone system in hypertensives treated with captopril.
    Novo S; Adamo L; Nardi E; Licata G; Strano A
    Prog Clin Biol Res; 1987; 242():387-92. PubMed ID: 3313416
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of captopril on urinary excretion of prostaglandins and renin-angiotensin-aldosterone system in normal subjects.
    Zacharieva S; Koev D; Andonova K
    Acta Physiol Pharmacol Bulg; 1989; 15(4):25-30. PubMed ID: 2699540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
    Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 1-Sar-8-Ile-angiotensin II on urinary prostaglandin excretion in patients with essential hypertension.
    Yasujima M; Abe K; Otsuka Y; Chiba S; Ritsu K; Irokawa N; Seino M; Sakurai Y; Saito K; Ito T; Yoshinaga K
    Tohoku J Exp Med; 1977 Nov; 123(3):271-8. PubMed ID: 601775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of felodipine on blood pressure and humoral factors in sodium-replete humans at rest and during exercise.
    Lijnen P; Hespel P; Fagard R; Staessen J; M'Buyamba-Kabangu JR; Moerman E; Amery A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S122-5. PubMed ID: 2455111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.